If either ACE2 or TMPRSS2 are rate‐limiting steps for virus entry, then there is a convincing case to assess expression of these two proteases as an estimate of infection risk and also a need to search for agents which inhibit the enzyme activities, downregulate expression, or even increase their turnover and/or modify their location. This evidence concerns the gene TMPRSS2 and infection.